Octride Depot 20mg

Octride depot 20mg injection contains octreotide as its active ingredient. This synthetic compound is derived from somatostatin, a naturally occurring substance in the human body that inhibits the effects of certain hormones, including growth hormones.

It is utilized to decrease the production of growth hormone in individuals with acromegaly (a condition characterized by excessive growth hormone production, leading to enlarged hands, feet, and facial features, along with joint pain and other symptoms) who are not candidates for surgery, radiation, or alternative medications.

Additionally, octreotide injection is employed to manage diarrhea and flushing associated with carcinoid tumors (slow-growing tumors that release natural substances causing symptoms) and vasoactive intestinal peptide-secreting adenomas (VIP-omas; tumors in the pancreas that release natural substances causing symptoms). It is also indicated to prevent complications following pancreatic surgery.

The octreotide depot 20mg injection is further indicated to halt bleeding and protect against re-bleeding from ruptured gastro-oesophageal varices in patients with chronic liver disease. The Octreotide Injection 20mg is prescribed for individuals with pituitary tumors that produce excessive thyroid-stimulating hormone (TSH) when other treatments (surgery or radiotherapy) are inappropriate or ineffective, and to cover the interim period after radiotherapy until it becomes fully effective.

Do not administer octride depot if you have an allergy to octreotide or any of the other components of this medication. Notify your physician if you have gallstones, abnormal blood sugar levels, vitamin B12 deficiency, or liver diseases.

Octride Depot 20mg injection may reduce your heart rate, and very high doses can lead to irregular heart rhythms; therefore, your doctor may regularly monitor your heart function during treatment. Inform your physician if you are pregnant or breastfeeding before starting the treatment.